Eastern Siberia PCOS Epidemiology & Phenotype Study

NCT05194384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1148

Last updated 2022-02-07

No results posted yet for this study

Summary

This multicenter, institution-based, cross-sectional study evaluates the prevalence of polycystic ovary syndrome (PCOS) and PCOS phenotype in Eastern Siberia - the unique region of the Russian Federation with a multi-raced population living in similar geographic and socio-economic conditions for centuries. Therefore, the investigators considered this population optimal for epidemiological research.

Conditions

  • PCOS

Sponsors & Collaborators

  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER
  • University of Southern California

    collaborator OTHER
  • Penn State University

    collaborator OTHER
  • Hacettepe University

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • Federal State Public Scientific Institution, Scientific Center for Family Health and Human Reproduction Problems

    lead OTHER

Principal Investigators

  • Larisa V Suturina, PhD, MD, Prof · Federal State Public Scientific Institution, Scientific Center for Family Health and Human Reproduction Problems. Irkutsk, Russia

  • Daria V Lizneva, PhD, MD · Icahn School of Medicine at Mount Sinai, New York, NY, USA

  • Frank Stanczyk, PhD, Prof · Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

  • Richard S Legro, MD,Prof · Hershey Medical Center, Penn State College of Medicine, Penn State University, Hershey, PA, USA

  • Bulent O Yildiz, PhD, MD, Prof · Hacettepe University School of Medicine, Hacettepe, Ankara, Turkey

  • Ricardo Azziz, PhD, MD, Prof · School of Public Health, University at Albany, SUNY, Albany, and School of Medicine, University of Alabama at Birmingham, Birmingham, USA

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-03
Primary Completion
2017-12-31
Completion
2019-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05194384 on ClinicalTrials.gov